Abstract: Methods and consumer products for detecting a metabolite, the method comprising: testing a urine sample from a subject for a metabolite selected from the group consisting of androstenediol, oxtenedioate, digydrouracil, heptanoylglutamine, pregnenetriol, sulfate, heptenoylglutamine, hexanoylglutamine, guanine, methylhexanoylglutamine, hexanoylglycine, hexenoylglycine, spermidine, diacetylspermine, acisoga and combinations thereof; and producing a metabolic profile for the metabolite.

Abstract: Methods and consumer products for detecting a metabolite, the method comprising: testing a urine sample from a subject for a metabolite selected from the group consisting of ascorbate, dehydroascorbate, CEHC-sulfate, CEHC-taurine, CEHC-glucronide, pantoate, 5-amino valerate, galactonate, phenylacetylalanine, methylcatecholsulfate, phenylacetylglutamine, carboxysuccinate, carboxyethylvaline, arabinose, threonate, methylcrotonylglycine, glucuronate, carboxyethylisoleucine, glycoursodeoxycholate, leucylalanine, lithocholatesulfate, allo-threonine, cholic, glucuronide and combinations thereof; and producing a metabolic profile for the metabolite.

Abstract: An auto-biodegradable absorbent article formed at least in part from a biodegradable polymer is provided that includes an inactivated microorganism product. The absorbent article contains one or more microorganisms that are designed to secrete an enzyme that degrades the biopolymer, which can be a polyhydroxybutyrate polymer. The microorganism can naturally secrete the enzyme or can be genetically modified to secrete the enzyme. The microorganisms or bacteria incorporated into the absorbent article are particularly selected based upon their salt tolerance and enzyme production at certain salt concentrations.

Abstract: A process and system are disclosed for increasing the rate of degradation of biopolymers in a solid waste depository, such as a landfill. A microorganism product, which can be an encapsulated product, is combined with the waste materials. The product contains one or more microorganisms that are designed to secrete an enzyme that degrades the biopolymer, which can be a polyhydroxybutyrate polymer. The microorganism can naturally secrete the enzyme or can be genetically modified to secrete the enzyme. The microorganisms or bacteria incorporated into the product are particularly selected in order to thrive in a particular environmental condition where the solid waste is located.

Abstract: Methods and compositions for modulating a bladder microbiome in a subject to improve bladder health are disclosed. The method can include providing a composition including a carrier and a bladder therapeutic agent. The bladder therapeutic agent can include isomaltulose, dextrin type 1, dextrin type 2, or combinations thereof. The method can further include administering the composition to a urogenital region of the subject. The method can include promoting a growth of Lactobacillus crispatus relative to Streptococcus anginosus within the bladder microbiome to modulate the bladder microbiome to improve bladder health.

Abstract: A group feed is displayed for a selected group by a private social network service. The group feed displays only threads with unviewed content along with a user actuatable display element that allows the user to switch to a feed that displays all content for the group.

Abstract: A group feed is displayed for a selected group by a private social network service. The group feed displays only threads with unviewed content along with a user actuatable display element that allows the user to switch to a feed that displays all content for the group.

Abstract: A method for detecting a malaria infection whereby providing a mouth cleansing product to a user then asking the user to blow or breathe onto or into a capture mechanism, wherein the capture mechanism may contain a thioether detection mechanism such as Michler's Hydrol; and analyzing whether a thioether detection mechanism displays any loss of the thioether detection mechanism. The invention also discloses a kit for indicating the presence of malaria by instructing the user to exhale through a capture mechanism after using a mouth cleansing product, wherein the kit includes a thioether detection mechanism such as Michler's Hydrol.

Abstract: Non-invasive systems for and methods of determining fluid characteristics within a fluid vessel are disclosed. The methods can include providing a sensor system comprising a single coil magnetic induction conductivity sensor, a processor, and a computing system configured to run an analytical coil-loss model. The method can include calibrating the sensor system to the vessel to provide a column calibration factor. The column calibration factor is dependent upon a cross-sectional area of the vessel and a wall thickness of the vessel. The single coil magnetic induction conductivity sensor can be placed near an external surface of the vessel at a portion of the vessel that is non-conductive. The method can include generating a coil loss measurement utilizing the single coil magnetic induction conductivity sensor and converting the coil loss measurement to a conductivity value of the fluid within the vessel.

Abstract: A group feed is displayed for a selected group by a private social network service. The group feed displays only threads with unviewed content along with a user actuatable display element that allows the user to switch to a feed that displays all content for the group.

Abstract: A group feed is displayed for a selected group by a private social network service. The group feed displays only threads with unviewed content along with a user actuatable display element that allows the user to switch to a feed that displays all content for the group.

Abstract: The invention provides inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents. The inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases. The peptide inhibitors of the invention can be formulated into therapeutic compositions, lotions, creams and wound dressings.

Abstract: Disclosed are screening processes for identification of compounds that may inhibit complex formation between C-reactive protein and fibronectin. Compounds identified by the disclosed methods may be utilized to inhibit the target analytes that are known to occur during skin aging as well as during the course of several diseases. Accordingly, inhibitory compounds identified by the disclosed methods may be utilized to prevent and treat damaged tissue, inflammatory conditions, cardiovascular conditions, renal conditions, periodontal conditions and obesity, among other conditions. For example, the compounds identified by the disclosed methods may be utilized to treat tissue that has suffered trauma, e.g., burns or wounds, as well as tissue that is inflamed due to any of several causes.

Abstract: The invention is directed to binding agents having binding loops and a stable beta barrel conformation. The binding loops of these agents can easily be altered so that the binding agent can bind any selected target molecule. A variety of methods for generating binding agents with different binding loops are also provided.

Abstract: The invention is directed to binding agents having binding loops and a stable beta barrel conformation. The binding loops of these agents can easily be altered so that the binding agent can bind any selected target molecule. A variety of methods for generating binding agents with different binding loops are also provided.

Abstract: Improved approaches to generate, distribute, redeem or return codes are disclosed. The codes can be used (i.e., redeemed) to purchase products from an online store. The codes can be electronically requested and received. In one embodiment, the codes can be acquired from a server via a network. The codes can be content specific codes that are redeemable for particular content, such as specific digital media assets. The codes can be returnable, and royalty obligations that may be due can be adjusted for returns.

Abstract: Diagnostic devices for detecting the presence of an analyte in a sample are provided. Devices of the present invention comprise a means for inducing a pressure differential on a sample to direct the sample to a test surface. In one embodiment, the means for inducing a pressure differential on a sample to direct the sample to a test surface comprises a syringe that can be used to draw a sample from an opening to a test surface. In other embodiments, the device also provides means for diluting a sample.

Abstract: Diagnostic devices for detecting the presence of an analyte in a sample are provided. Devices of the present invention comprise a means for inducing a pressure differential on a sample to direct the sample to a test surface. In one embodiment, the means for inducing a pressure differential on a sample to direct the sample to a test surface comprises a syringe that can be used to draw a sample from an opening to a test surface. In other embodiments, the device also provides means for diluting a sample. In yet other embodiments, the device also provides a means.

Abstract: The invention provides proteinoid microsphere made up of a mixture of thermally condensed amino acids that are crosslinked with a crosslinker reagent. The proteinoid microspheres of the invention may be used to encapsulate a material or a compound and to provide slow, sustained or timed release of the material or compound. The proteinoid microspheres are stable in solution until exposed to a reducing agent. However, the in vivo environment provides a sufficient reduction potential to provide slow, sustained release of materials contained therein from the proteinoid microspheres of the present invention.

Abstract: Diagnostic devices, systems and methods for detecting the presence of an analyte in a sample are provided. In one embodiment, the device comprises a substrate, a binder printed in a pattern onto a surface of the substrate, and a means for directing a sample towards the surface of the substrate that is printed with the binder. Systems of the present invention further include a light source that can be directed through the aforementioned means or another opening to the binder-printed surface to test for diffraction.